SCHEMBL765316

SCHEMBL765316

COC(=O)Nc1sccc1C

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
HPGD P15428 3/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 3/20 0.44
PKM P14618 2/20 0.44
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
TP53 P04637 1/20 0.42
ALDH1A1 P00352 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PTK2 Q05397 1/20 0.41
GAA P10253 1/20 0.40
PPARG P37231 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
GSK3B P49841 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6857304 0.83 PTPN2 (0.48) SMN1; SMN2MEN1KMT2AHPGDMAPT
SCHEMBL5049650 0.83 PKM (0.45) SMN1; SMN2MEN1KMT2AHPGDMAPT
SCHEMBL2928945 0.82 CA12 (0.45) SMN1; SMN2MEN1KMT2AHPGDMAPT
SCHEMBL12213152 0.82 PTK2 (0.59) SMN1; SMN2HPGDMAPTPKMRAB9A
SCHEMBL11777129 0.80 GSK3B (0.43) SMN1; SMN2MEN1KMT2AHPGDMAPT
SCHEMBL3337813 0.80 PTK2 (0.49) SMN1; SMN2MEN1KMT2AHPGDMAPT
SCHEMBL8090363 0.77 MAPT (0.43) HPGDMAPTPKMRAB9ANPC1
SCHEMBL1380571 0.76 TGM2 (0.49) SMN1; SMN2HPGDLMNAPKMRAB9A
SCHEMBL11564309 0.76 NPC1 (0.62) SMN1; SMN2MEN1KMT2ALMNARAB9A
SCHEMBL6716911 0.75 PTK2 (0.35) SMN1; SMN2MEN1KMT2AHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776011-B1 FUNGICIDAL COMPOSITION CONTAINING AN ACID AMIDE DERIVATIVE ISHIHARA SANGYO KAISHA (JP) 2012-03-21 EP disclosed
US-8039420-B2 Fungicidal composition containing acid amide derivative ISHIHARA SANGYO KAISHA, LTD. (JP) 2011-10-18 US disclosed
US-7829501-B2 Fungicidal composition containing acid amide derivative ISHIHARA SANGYO KAISHA, LTD. (JP) 2010-11-09 US disclosed
US-20100261735-A1 FUNGICIDAL COMPOSITION CONTAINING ACID AMIDE DERIVATIVE ISHIHARA SANGYO KAISHA, LTD. (JP) 2010-10-14 US disclosed
US-20100261675-A1 FUNGICIDAL COMPOSITION CONTAINING ACID AMIDE DERIVATIVE ISHIHARA SANGYO KAISHA, LTD. (JP) 2010-10-14 US disclosed
US-20080318779-A1 N-[(4'-methoxy-2'-methyl-1,1-dimethyl)phenacyl]-3-methyl-2-thiophenecarboxamide and another fungicide or an antibiotic; controlling noxious fungi at a low dose; Oomycetes, Ascomycetes, Basidiomycetes, Deuteromycetes particularly effective against Ascomycetes or Deuteromycetes; plant diseases ISHIHARA SANGYO KAISHA LTD (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318779-A1 N-[(4'-methoxy-2'-methyl-1,1-dimethyl)phenacyl]-3-methyl-2-thiophenecarboxamide and another fungicide or an antibiotic; controlling noxious fungi at a low dose; Oomycetes, Ascomycetes, Basidiomycetes, Deuteromycetes particularly effective against Ascomycetes or Deuteromycetes; plant diseases AADAC, NAT1, TH SMN1; SMN2 1332/4885MEN1 2049/4885KMT2A 237/4885
US-20100261675-A1 FUNGICIDAL COMPOSITION CONTAINING ACID AMIDE DERIVATIVE CBR3, AADAC, NAT1 SMN1; SMN2 1386/4885MEN1 3533/4885KMT2A 818/4885
US-20100261735-A1 FUNGICIDAL COMPOSITION CONTAINING ACID AMIDE DERIVATIVE CBR3, AADAC, NAT1 SMN1; SMN2 1386/4885MEN1 3533/4885KMT2A 818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.